Aleksei Titov

913 citations
13 papers · 368 indexed · h-index 7
Topics
CAR-T cell therapy research (7 papers)Virus-based gene therapy research (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
Journals
SHILAP Revista de lepidopterologíaNature reviews. CancerFrontiers in Immunology

In The Last Decade

Aleksei Titov

12 papers receiving 365 citations

Peers

Aleksei Titov
Comparison fields: 5 of 52
  • Oncology 214
  • Immunology 147
  • Molecular Biology 122
  • Genetics 70
  • Biomedical Engineering 61
Replace Laura Kummer with:
Laura Kummer Germany
Ruimin Hong China
Mina O. Seedhom United States
Anthony Leonardi United States
Houli Zhao China
Vania Baldan United Kingdom
Ting Lu United States
Paul Castillo United States
Conor Gruber United States
Reyisa Bughda United Kingdom
Aleksei Titov relative to Laura Kummer Germany Laura Kummer's profile →
Citations per field
00.5×1.5×
Laura Kummer · 1×
Citations per year

Countries citing papers authored by Aleksei Titov

Since Specialization
Citations

This map shows the geographic impact of Aleksei Titov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksei Titov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksei Titov more than expected).

Fields of papers citing papers by Aleksei Titov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksei Titov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksei Titov. The network helps show where Aleksei Titov may publish in the future.

Co-authorship network of co-authors of Aleksei Titov

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksei Titov. A scholar is included among the top collaborators of Aleksei Titov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksei Titov. Aleksei Titov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 5
3 2
4 9
5 38
6 72
7 73
8 2
9 61
10 1
11 6
12 85
13 14

About Aleksei Titov

Aleksei Titov is a scholar working on Infectious Diseases, Hematology and Oncology, having authored 13 papers that have together received 368 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Oncology (214 citations), Immunology (147 citations) and Infectious Diseases (59 citations). Aleksei Titov has collaborated with scholars based in Russia, United Kingdom and Czechia. Frequent co-authors include Alexey Petukhov, Emil Bulatov, Regina Miftakhova, Aygul Valiullina, Ekaterina Zmievskaya, Albert A. Rizvanov, Irina Ganeeva, Mauro Piacentini, Surinder M. Soond and Andrey Zaritskey. Their work appears in journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026